Tumor subtypes and survival in male breast cancer

[1]  E. Winer,et al.  Efficacy of neoadjuvant chemotherapy (NAC) in male breast cancer (MaBC) compared with female breast cancer (FBC): A National Cancer Database (NCDB) study. , 2020 .

[2]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[3]  J. Leone,et al.  Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study , 2019, American journal of clinical oncology.

[4]  D. Goulis,et al.  Breast Cancer in Men. , 2018, The New England journal of medicine.

[5]  G. Sledge,et al.  Molecular Characterization and Mortality From Breast Cancer in Men. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. M. Jerez,et al.  Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes , 2018, Modern Pathology.

[7]  Melissa P. Murray,et al.  Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  P. V. van Diest,et al.  Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. , 2017, European journal of cancer.

[9]  Shuiping Gao,et al.  Clinicopathological characteristics and survival outcomes of male breast cancer according to race: A SEER population-based study. , 2017, Oncotarget.

[10]  Shuiping Gao,et al.  Clinicopathological characteristics and survival outcomes of male breast cancer according to race: A SEER population-based study , 2017, Oncotarget.

[11]  B. Leone,et al.  Prognostic significance of tumor subtypes in male breast cancer: a population-based study , 2015, Breast Cancer Research and Treatment.

[12]  A. Jemal,et al.  Black/White Disparities in Receipt of Treatment and Survival Among Men With Early-Stage Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Hongjian Yang,et al.  The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study. , 2013, Breast.

[14]  G. Hortobagyi,et al.  Male breast cancer according to tumor subtype and race , 2013, Cancer.

[15]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[16]  G. Ball,et al.  A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences , 2012, Breast Cancer Research and Treatment.

[17]  P. Diest,et al.  Molecular subtyping of male breast cancer by immunohistochemistry , 2012, Modern Pathology.

[18]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[19]  N. Sneige,et al.  Immunohistochemical characterization of subtypes of male breast carcinoma , 2009, Breast Cancer Research.

[20]  G. Hortobagyi,et al.  Breast carcinoma in men , 2004, Cancer.

[21]  R. Jackson,et al.  Breast cancer in men. , 2003, Annals of internal medicine.

[22]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[23]  L. Brinton,et al.  Is Male Breast Cancer Similar or Different than Female Breast Cancer? , 2004, Breast Cancer Research and Treatment.